GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Memphasys Ltd (FRA:IG7) » Definitions » 5-Year Yield-on-Cost %

Memphasys (FRA:IG7) 5-Year Yield-on-Cost % : 0.00 (As of May. 24, 2024)


View and export this data going back to 2019. Start your Free Trial

What is Memphasys 5-Year Yield-on-Cost %?

Memphasys's yield on cost for the quarter that ended in Dec. 2023 was 0.00.


The historical rank and industry rank for Memphasys's 5-Year Yield-on-Cost % or its related term are showing as below:



FRA:IG7's 5-Year Yield-on-Cost % is not ranked *
in the Biotechnology industry.
Industry Median: 1.73
* Ranked among companies with meaningful 5-Year Yield-on-Cost % only.

Competitive Comparison of Memphasys's 5-Year Yield-on-Cost %

For the Biotechnology subindustry, Memphasys's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Memphasys's 5-Year Yield-on-Cost % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Memphasys's 5-Year Yield-on-Cost % distribution charts can be found below:

* The bar in red indicates where Memphasys's 5-Year Yield-on-Cost % falls into.



Memphasys 5-Year Yield-on-Cost % Calculation

Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.

Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.

Therefore, Yield-on-Cost of Memphasys is calculated as

Yield-on-Cost=Dividend Yield %*(1+Dividend Growth Rate)^5

Memphasys  (FRA:IG7) 5-Year Yield-on-Cost % Explanation

Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.


Memphasys 5-Year Yield-on-Cost % Related Terms

Thank you for viewing the detailed overview of Memphasys's 5-Year Yield-on-Cost % provided by GuruFocus.com. Please click on the following links to see related term pages.


Memphasys (FRA:IG7) Business Description

Traded in Other Exchanges
Address
30 Richmond Road, Homebush, Sydney, NSW, AUS, 2140
Memphasys Ltd is an Australian-based emerging small-cap reproductive biotechnology company. It develops and commercializes novel reproduction and fertility solutions for humans and animals. Its technology includes Hydrogel and other polymer membrane technology development. The company is developing novel medical devices, diagnostics, and media with applications to assisted reproduction technologies, including IVF in humans and artificial insemination in animals.

Memphasys (FRA:IG7) Headlines

No Headlines